High- versus low-dose ACE inhibition in chronic heart failure: A double-blind, placebo-controlled study of imidapril

This publication has 35 references indexed in Scilit:

• Large Differences in Drug Treatment of Chronic Heart Failure Between the European Countries
  Journal of the American College of Cardiology, 1998
• Effects of angiotensin-converting enzyme inhibitor on plasma b-type natriuretic peptide levels in patients with acute myocardial infarction
  Journal of Cardiac Failure, 1997
• Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?
  Journal of the American College of Cardiology, 1996
• The Management of Chronic Heart Failure
  New England Journal of Medicine, 1996
• Prolonging Action of Imidapril on the Lifespan Expectancy of Cardiomyopathic Hamsters
  Journal of Cardiovascular Pharmacology, 1996
• ACE inhibitor co-therapy in patients with heart failure: Rationale for the Randomized Aldactone Evaluation Study (RALES)
  European Heart Journal, 1995
• Imidapril hydrochloride in essential hypertension: a double-blind comparative study using enalapril maleate as a control
  Journal Of Hypertension, 1995
• ACE inhibitors for heart failure: a question of dose
  Heart, 1994
• Dose finding studies with imidapril—a new ACE inhibitor.
  British Journal of Clinical Pharmacology, 1994
• Pharmacological Studies on TA-6366, a New ACE Inhibitor: II. Effect of Long-Term Administration from the Pre-Hypertensive Stage on Blood Pressure, Relative Heart Weight and ACE Activity of Various Tissues in Spontaneously Hypertensive Rats(SHRs).
  The Japanese Journal of Pharmacology, 1991